1.Radiofrequency ablation for pancreatic insulinoma: an accident or not
Wenbing SUN ; Xiangtao WANG ; Zonghai XIN
Chinese Journal of Hepatobiliary Surgery 2017;23(1):5-7
Insulinoma is the most common functional pancreatic neuroendocrine tumor.Surgical removal or enucleation is the most commonly used treatment.Insulinomas are usually benign,solitary and small.So they are theoretically the good indication for radiofrequency ablation (RFA) treatment.In 2009,Limmer et al ever reported the first case of insulinoma who were successfully treated by RFA.To date,5 similar articles in English have been published,reporting 7 cases in total.In the recent year,we successfully treated 2 cases with insulinoma (one in pancreatic cauda and the other in pancreatic body).All the 2 cases got complete remission with quick alleviation of clinical symptoms and without conplications.The data of these 9 cases showed that RFA is a safe and effective treatment for insulinoma,and for selected patients,it can be recommended as a treatment of first choice.
2.Radiofrequency ablation for hepatic hemangiomas: a Chinese consensus statement
Jun GAO ; Ruifang FAN ; Jiayin YANG ; Yan CUI ; Jiansong JI ; Kuansheng MA ; Xiaolong LI ; Long ZHANG ; Chongliang XU ; Xinliang KONG ; Shan KE ; Xuemei DING ; Shaohong WANG ; Jingjing SONG ; Bo ZHAI ; Chunmin NING ; Shigang GUO ; Zonghai XIN ; Yonghong DONG ; Jun LU ; Huaqiang ZHU ; Wenbing SUN
Chinese Journal of Hepatobiliary Surgery 2017;23(5):289-295